Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TET2 |
Variant | P363L |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | TET2 P363L does not lie within any known functional domains of the Tet2 protein (UniProt.org). P363L results in conversion of 5mC to 5hmC similar to wild-type Tet2 in a patient sample (PMID: 26284134), but has not been fully biochemically characterized and therefore, its effect on Tet2 protein funciton is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
TET2 mutant TET2 P363L |
Transcript | NM_001127208.3 |
gDNA | chr4:g.105235030C>T |
cDNA | c.1088C>T |
Protein | p.P363L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_006714242 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
NM_017628.4 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_024454103.2 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_047415839.1 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_006714242.3 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_005263082.3 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_024454103.1 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
NM_017628 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_024454102.2 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_047415841.1 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
NM_001127208 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_005263082 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_024454102.1 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_047415842.1 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_017008319.2 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_017008319.1 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
NM_001127208.2 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_047415843.1 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
NM_001127208.3 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_047415840.1 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
NM_017628.4 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_017008319 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_006714242.4 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
XM_005263082.4 | chr4:g.105235030C>T | c.1088C>T | p.P363L | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|